U.S. Attorney Announces $22.8 Million Settlement Of Civil Fraud Lawsuit Against Vitamin Importer For Underpaying Customs Duties Owed On Products Imported Into The United States

Source: United States Department of Justice News

International Vitamins Corporation Admits That It Misclassified Many Imports As Duty-Free And Failed To Pay Back Duties Owed

Damian Williams, the United States Attorney for the Southern District of New York, AnnMarie R. Highsmith, Executive Assistant Commissioner for U.S. Customs and Border Protection’s (“CBP”) Office of Trade, and Francis Russo, Director of CBP Field Operations New York, announced today that the United States has filed and settled a civil lawsuit against International Vitamins Corporation (“IVC”), a United States-based company that imports and sells vitamins and nutritional supplements from China.  The settlement resolves claims that, for years, IVC defrauded the United States by misclassifying more than 30 of its products under the Harmonized Tariff Schedule (“HTS”) in order to avoid paying customs duties and by failing to pay back duties owed to the United States even after IVC finally corrected its longstanding misclassifications.

Under the settlement agreement approved by U.S. District Judge Mary Kay Vyskocil, IVC will pay $22,865,055 to the United States.  As part of the settlement agreement, IVC also made admissions regarding its conduct.  IVC admitted that, between 2015 and 2019, it utilized HTS classifications for 32 products it imported from China (the “Covered Products”) that carried duty-free rates, even though those products, if accurately classified, would have been subject to the payment of duties.  IVC also admitted that even after it retained a consultant in 2018 who informed IVC that it had been misclassifying the Covered Products, IVC did not implement the correct classifications for over nine months and never remitted duties that it had underpaid to the United States because of its misclassification of the Covered Products.

U.S. Attorney Damian Williams said: “IVC engaged in a fraudulent scheme to avoid customs duties owed to the United States by misclassifying many of its products as duty-free when importing them from China.  Worse yet, IVC made no effort to right its wrongs even after acknowledging internally that it had underpaid millions of dollars of duties owed.  This Office is committed to combatting customs fraud by holding companies accountable when they attempt to avoid paying what they owe when importing goods from abroad.”

CBP Executive Assistant Commissioner AnnMarie R. Highsmith said: “This case reflects a pattern of behavior in which this company knowingly misclassified imported merchandise to avoid paying duties.  They did so despite clear prior rulings by CBP on the correct classification for this specific type of product.  Their failure to adhere to the customs laws, which are designed to protect U.S. revenue and U.S. consumers, will cost the company more than $22.8 million under the terms of a civil settlement with the United States.  The dedication of the men and women of the CBP Office of Trade, the Office of Chief Counsel New York, and the United States Attorney’s Office to protect a fair and competitive trade environment is vital to facilitating lawful trade.”

CBP Director of Field Operations Francis Russo said: “U.S. Customs and Border Protection provided the critical link to an ongoing investigation into an attempt to circumvent payment of proper duties.  This case serves as a great example of collaborative law enforcement efforts to uncover and dismantle enterprises that seek to defraud the United States government for personal gain while causing economic harm to their competitors.”

As alleged in the Complaint filed in Manhattan federal court:

From January 1, 2015, through September 13, 2019 (the “Covered Period”), IVC made thousands of entries of the Covered Products (consisting of raw and bulk vitamins and nutritional supplements) into the United States from China while materially misreporting to CBP the duty rates applicable to those products under the HTS.  IVC knowingly submitted or caused its customs brokers to submit entry documents to CBP that contained false classifications of the Covered Products in order to avoid paying duties owed and failed to remit underpaid duties even after IVC confirmed that the classifications it had used were incorrect.

IVC utilized inaccurate HTS classifications for the Covered Products despite receiving repeated notices from CBP informing IVC that the classifications it had been using for similar goods were erroneous.  After continuing to use the incorrect HTS classifications for more than three years, IVC retained a consultant to analyze the propriety of its classifications.  Even after the consultant confirmed that IVC had been misclassifying the Covered Products under the HTS, IVC persisted in using its incorrect classifications for these goods for over nine months.  Throughout, IVC provided the incorrect classifications to its customs brokers, knowing that they would rely on those classifications when preparing documents to be submitted to CBP on IVC’s behalf.

When IVC finally adopted the correct classifications for the Covered Products, IVC made no effort to pay back the duties that it had long owed to the United States because of its pervasive misclassifications.  As a result, IVC underpaid millions of dollars of duties owed to CBP for its imports.

In the settlement agreement, IVC admitted, acknowledged, and accepted responsibility for the following conduct:

  • During the Covered Period, IVC’s customs brokers used information provided by IVC to prepare and submit customs entry summaries to CBP relating to imports of the Covered Products.  IVC knew that its customs brokers would rely on the information it provided when classifying the Covered Products and preparing the entry summaries to be submitted to CBP. 
  • During the Covered Period, IVC provided its customs brokers with HTS classifications for the Covered Products that applied to medicaments and vitamins and that would incur no duties.  The Covered Products should have been classified as food preparations subject to the payment of duties.  IVC continued providing its customs brokers with these inaccurate HTS classifications even after CBP issued Notices of Action to IVC in 2016 and 2017 regarding classification errors made by IVC for similar non-Covered Products, namely, incorrectly classifying the similar non-Covered Products as duty-free when the correct classifications were for food preparations subject to duties.
  • In the fall of 2018, IVC retained a consultant to review the HTS classifications IVC was using for all of the products IVC was then importing into the United States, including the Covered Products.  After analyzing the 134 products, the consultant provided IVC with the correct HTS classifications for each of the Covered Products.  The corrected codes carried higher duty rates than the HTS classifications IVC was using at the time.  As a result, IVC had underpaid duties on the Covered Products.
  • IVC did not implement the corrected codes for the Covered Products that were imported into the United States on entry documentation submitted to CBP until around September 13, 2019.  Soon after, an IVC executive explained his view “that as each item is reviewed and corrected,” IVC had “a very strong go forward but the clean up is tough.”  IVC never remitted the duties it had underpaid for the Covered Products, apart from in response to several discrete Notices of Action.
  • As a result, IVC, through its customs brokers, misclassified the Covered Products on entry documents filed with CBP and, throughout the Covered Period, routinely underpaid customs duties on the Covered Products. 

*                *                *

In connection with the filing of the lawsuit and settlement, the Government joined a whistleblower lawsuit that had been previously filed under seal pursuant to the False Claims Act.

Mr. Williams thanked CBP for its investigative efforts and ongoing support and assistance with the case.

This case is being handled by the Office’s Civil Frauds Unit.  Assistant U.S. Attorney Zachary Bannon is in charge of the case.

Prince William Drug Dealer Sentenced for Causing Multiple Overdoses

Source: United States Department of Justice News

ALEXANDRIA, Va. – A Dumfries man was sentenced today to 30 years in prison for distribution of fentanyl resulting in death and serious bodily injury, and possession with the intent to distribute fentanyl.

According to court documents, on September 21, 2021, Michael Vaughn, 28, distributed cocaine laced with fentanyl at a party at an apartment in the Skyline area of Fairfax County. Six individuals took the substance, believing it to be cocaine. All six suffered overdoses and were transported to area hospitals. Five of the overdose victims were able to be saved by the administration of Narcan. However, the sixth individual died as a result of a fentanyl overdose. At trial, the evidence showed that Vaughn had intentionally added fentanyl to the cocaine. Additionally, Vaughn possessed approximately 60 additional grams of fentanyl powder at his residence when he was arrested on October 20, 2021.

Jessica D. Aber, U.S. Attorney for the Eastern District of Virginia; Jarod Forget, Special Agent in Charge for the Drug Enforcement Administration’s (DEA) Washington Division; and Kevin Davis, Fairfax County Chief of Police, made the announcement after sentencing by U.S. District Judge Rossie D. Alston.

Significant assistance was provided by the Prince William County Police Department.

Assistant U.S. Attorneys Rachael C. Tucker and Michael P. Ben’Ary prosecuted the case.

A copy of this press release is located on the website of the U.S. Attorney’s Office for the Eastern District of Virginia. Related court documents and information are located on the website of the District Court for the Eastern District of Virginia or on PACER by searching for Case No. 1:21-cr-261.

Conspirators Sentenced in Multimillion-Dollar Reptile Smuggling Scheme

Source: United States Department of Justice News

Today, Ka Yeung Marvin Chan, a Canadian national, was sentenced to a term of 14 months in prison followed by two years of supervised release for his role in a conspiracy to smuggle reptiles from the United States to Asia.

Chan is the last of three defendants sentenced for their roles in this reptile trafficking scheme. According to court documents and information in the public record, Chan and another conspirator, Daisuke Miyauchi, owned and operated businesses overseas and engaged in the sale of reptiles. Both men periodically traveled to the United States to purchase, among other things, ball pythons, blood pythons, common tegus, Argentine tegus and iguanas, which are protected under Appendix II of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). Chan and Miyachi then worked with co-conspirator Chun Ku to smuggle the reptiles out of the country using Ku’s Master File CITES permit and fraudulent export paperwork. CITES regulates trade in endangered or threatened species through permit requirements.

Over a seven-year period, the conspirators collectively engaged in at least 107 separate criminal acts, smuggling to Asia a total of 8,738 CITES II protected animals with a retail market value in excess of $5.13 million. In addition to the CITES II species, the fraudulent shipments contained 61,622 non-CITES animals, many of which were also smuggled. 

Chan and his co-conspirators each pleaded guilty to conspiracy to falsely label wildlife being exported from the United States and to smuggle goods and merchandise out of the United States as well as submitting false records and false identification of wildlife intended to be exported. 

On Nov. 18, 2022, Ku was sentenced to concurrent terms of one year and one day imprisonment, two years’ supervised release and a $20,000 fine. On Feb. 22, 2022, Miyauchi was sentenced to concurrent terms of 13 months in prison. Each received favorable consideration at sentencing due to their cooperation with authorities during the investigation.

“The defendants abused a system designed to streamline the exportation of captive-bred reptiles for law-abiding breeders. They allowed other business owners to sell and ship reptiles to buyers in Asia without going through the federal agency vetting process,” said Assistant Attorney General Todd Kim of the Justice Department’s Environment and Natural Resources Division. “These prosecutions reflect law enforcement’s commitment to combat illegal wildlife trafficking.”

“The U.S. Fish and Wildlife Service, Office of Law Enforcement is committed to conduct criminal investigations combating the illegal international reptile trade,” said Assistant Director Ed Grace of the Fish and Wildlife Service Office of Law Enforcement “The Office of Law Enforcement takes violations of the Lacey Act seriously. The three-year long investigation involving the three defendants uncovered at least 107 criminal acts, a combined monetary value of $5,134,000, and involved a conspiracy to violate the Lacey Act, smuggle CITES Appendix II reptiles out of the United States, and create and submit fraudulent documents to the government prior to export. We will continue to work combating wildlife smuggling while striving to maintain the integrity of the legal export process.”

The U.S. Fish and Wildlife Service investigated the case with special thanks to U.S. Fish and Wildlife’s Division of Management Authority.

Assistant U.S. Attorney Thomas Watts-FitzGerald for the Southern District of Florida and Senior Trial Attorney Banumathi Rangarajan of the Environment and Natural Resources Division’s Environmental Crimes Section prosecuted the case.

Two Florida Doctors Convicted in $31 Million Medicare Fraud Scheme

Source: United States Department of Justice Criminal Division

A federal jury convicted two Florida doctors today for their roles in a scheme to defraud Medicare by submitting over $31 million in claims for expensive durable medical equipment (DME) that Medicare beneficiaries did not need and that were procured through the payment of kickbacks.

According to court documents and evidence presented at trial, Dean Zusmer, 54, of Miami, was a chiropractor who conspired with others to steal millions of dollars from Medicare. Zusmer owned one of four DME companies that collectively billed Medicare over $31 million for medically unnecessary DME, of which over $15 million was paid. Zusmer and his co-conspirators, including Jeremy Waxman, acquired patient referrals and signed doctors’ orders by paying kickbacks to marketers who used overseas call centers to solicit patients and telemedicine companies to procure prescriptions for unnecessary braces for these patients. 

Court documents and evidence presented at trial further demonstrated that Lawrence Alexander, M.D., 45, of Miami, was an orthopedic surgeon who owned one of the DME companies with Waxman and concealed both his and Waxman’s roles in the scheme by putting the DME company in the name of one of Alexander’s family members. 

Zusmer was convicted of conspiracy to commit health care fraud, health care fraud, conspiracy to pay illegal health care kickbacks, paying illegal health care kickbacks, and false statements relating to health care matters. He is scheduled to be sentenced on April 20 and faces a maximum penalty of 10 years in prison on each of the following counts: conspiracy to commit health care fraud; health care fraud; and paying illegal health care kickbacks. Zusmer faces a maximum penalty of five years in prison for the following counts: conspiracy to pay illegal health care kickbacks and false statements relating to health care matters.

Alexander was convicted of false statements relating to health care matters. He is scheduled to be sentenced on April 20 and faces a maximum penalty of five years in prison. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

Waxman was previously sentenced to over 15 years in prison for his role in the scheme.

Assistant Attorney General Kenneth A. Polite, Jr. of the Justice Department’s Criminal Division; Assistant Director Luis Quesada of the FBI Criminal Investigative Division; Special Agent in Charge Robert M. DeWitt of the FBI Miami Field Office; and Special Agent in Charge Omar Pérez Aybar of the Department of Health and Human Services Office of the Inspector General (HHS-OIG), Miami Regional Office made the announcement.

The FBI and HHS-OIG investigated the case.

Trial Attorneys Catherine Wagner, Patrick Queenan, Meredith Hough, Jamie de Boer, and Keith Clouser of the Criminal Division’s Fraud Section are prosecuting the case.

The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, comprised of 15 strike forces operating in 24 federal districts, has charged more than 4,200 defendants who collectively have billed the Medicare program for more than $19 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with the Office of the Inspector General for the Department of Health and Human Services, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at https://www.justice.gov/criminal-fraud/health-care-fraud-unit.